Bolt Biotherapeutics, Inc.
BOLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $11 | $307 | $410 |
| - Cash | $18 | $10 | $8 | $7 |
| + Debt | $24 | $24 | $25 | $25 |
| Enterprise Value | $16 | $26 | $323 | $428 |
| Revenue | $2 | $2 | $1 | $0 |
| % Growth | 20.2% | 47.6% | – | – |
| Gross Profit | $2 | $2 | $1 | -$0 |
| % Margin | 86.6% | 100% | 100% | – |
| EBITDA | -$7 | -$9 | -$12 | -$16 |
| % Margin | -316% | -491.3% | -958.8% | – |
| Net Income | -$7 | -$9 | -$11 | -$16 |
| % Margin | -329.4% | -474.6% | -903.4% | – |
| EPS Diluted | -3.722 | -4.46 | -0.29 | -0.42 |
| % Growth | 16.5% | -1,437.9% | 31% | – |
| Operating Cash Flow | -$10 | -$10 | -$13 | -$14 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$10 | -$10 | -$13 | -$14 |